Smartwatch-Based Blood Pressure Measurement Demonstrates Insufficient Accuracy

BACKGROUND: Novel smartwatch-based cuffless blood pressure (BP) measuring devices are coming to market and receive FDA and CE labels. These devices are often insufficiently validated for clinical use. This study aims to investigate a recently CE-cleared smartwatch using cuffless BP measurement in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Falter, Maarten, Scherrenberg, Martijn, Driesen, Karen, Pieters, Zoë, Kaihara, Toshiki, Xu, Linqi, Caiani, Enrico Gianluca, Castiglioni, Paolo, Faini, Andrea, Parati, Gianfranco, Dendale, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309348/
https://www.ncbi.nlm.nih.gov/pubmed/35898281
http://dx.doi.org/10.3389/fcvm.2022.958212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309348/
https://www.ncbi.nlm.nih.gov/pubmed/35898281
http://dx.doi.org/10.3389/fcvm.2022.958212

Ejemplares similares